Align Sugar-binding transport ATP-binding protein aka MalK1 aka TT_C0211, component of The trehalose/maltose/sucrose/palatinose porter (TTC1627-9) plus MalK1 (ABC protein, shared with 3.A.1.1.24) (Silva et al. 2005; Chevance et al., 2006). The receptor (TTC1627) binds disaccharide alpha-glycosides, namely trehalose (alpha-1,1), sucrose (alpha-1,2), maltose (alpha-1,4), palatinose (alpha-1,6) and glucose (characterized)
to candidate WP_081948971.1 JH15_RS09915 ABC transporter ATP-binding protein
Query= TCDB::Q72L52 (376 letters) >NCBI__GCF_000759345.1:WP_081948971.1 Length = 389 Score = 304 bits (778), Expect = 3e-87 Identities = 169/363 (46%), Positives = 230/363 (63%), Gaps = 26/363 (7%) Query: 3 KVRLEHVWKRFGKVVAVKDFNLETEDGEFVVFVGPSGCGKTTTLRMIAGLEEISEGNIYI 62 ++RLE+V K++G AV + + G+FV+ +GPSGCGK+TTLRMIAGLE+ S G I+I Sbjct: 7 RIRLENVSKQWGDTPAVDGISFDVTPGQFVILLGPSGCGKSTTLRMIAGLEQASSGRIHI 66 Query: 63 GDRLVNDVPPKDRDIAMVFQNYALYPHMNVYENMAFGLRLRRYPKDEIDRRVKEAARILK 122 GDR V +PP DR ++MVFQNYAL+PH+NV EN+ FGLR RR E R+ AA+++ Sbjct: 67 GDRDVTSLPPGDRGLSMVFQNYALFPHLNVAENIVFGLRSRRVAGAERRERLARAAKLVD 126 Query: 123 IEHLLNRKPRELSGGQRQRVAMGRAIVREPKVFLMDEPLSNLDAKLRVEMRAEIAKLQRR 182 +E L+RKP +LSGGQRQRVA+ RAI+ E + LMDEPLSNLDA+LR EMR EI LQRR Sbjct: 127 LEAYLDRKPAQLSGGQRQRVALARAIIAEHPICLMDEPLSNLDARLRGEMRREIKALQRR 186 Query: 183 LGVTTIYVTHDQVEAMTLGHRIVVMKDGEIQQVDTPLNLYDFPANRFVAGFIGSPSMNFV 242 LG+T IYVTHDQVEAM++G R+++M+ G I Q DTP LY PA F A FIGSP+MN + Sbjct: 187 LGMTVIYVTHDQVEAMSMGDRVILMQGGRIVQDDTPSELYRRPATAFAASFIGSPAMNLL 246 Query: 243 -----RAGVEVQGEKVYLVAPGFRIRANAVLGSALKPYAGKEVWLGVRPEHLGLKGYTTI 297 G ++GE P + ++ +GS +GVRPE + + + Sbjct: 247 PLAAASDGAVIEGE------PRCAVASHEAVGSQ----------IGVRPEDIRIAAW--- 287 Query: 298 PEEENVLRGEVEVVEPLGAETEIHVAVNGTLLVAKVDGHAPVKPGDKVELLADTQRLHAF 357 + + E + E LGA++ + + V L A++DG AP P + L + H F Sbjct: 288 --DAPGVPAEWQDTEYLGADSIVRLKVGEHELRARLDGPAPEHPPGRCRLQWSAEAAHFF 345 Query: 358 DLE 360 D + Sbjct: 346 DAD 348 Lambda K H 0.320 0.139 0.400 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 406 Number of extensions: 18 Number of successful extensions: 2 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 376 Length of database: 389 Length adjustment: 30 Effective length of query: 346 Effective length of database: 359 Effective search space: 124214 Effective search space used: 124214 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.8 bits) S2: 50 (23.9 bits)
This GapMind analysis is from Sep 24 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory